View ValuationExtendicare 향후 성장Future 기준 점검 1/6Extendicare의 수익이 증가할 것으로 예상됨입니다.핵심 정보n/a이익 성장률n/aEPS 성장률Healthcare 이익 성장52.6%매출 성장률14.1%향후 자기자본이익률n/a애널리스트 커버리지Good마지막 업데이트15 May 2026최근 향후 성장 업데이트Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.Price Target Changed • Mar 01Price target increased by 15% to CA$29.08Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year.Price Target Changed • Nov 26Price target increased by 16% to CA$22.25Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year.Price Target Changed • Nov 14Price target increased by 14% to CA$18.75Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year.Price Target Changed • Feb 05Price target increased by 8.6% to CA$11.40Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year.Price Target Changed • Aug 14Price target increased by 10% to CA$9.17Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year.모든 업데이트 보기Recent updatesRecent Insider Transactions • May 17Independent Director recently bought CA$347k worth of stockOn the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months.Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.Reported Earnings • May 11First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025)First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year.속보 • May 10Extendicare Expands Home Health Care With Major Acquisitions and Raises DividendExtendicare reported strong Q1 2026 results, with home health care cited as a key driver of performance. The company expanded its home health footprint through acquisitions of CBI Home Health, Closing the Gap and nine Class C long-term care homes. Extendicare issued $450 million of senior unsecured notes, restructured its credit facilities and announced a 5.0% increase in its monthly dividend. For you as an investor, the update highlights a clear push into home health services, supported by sizable acquisitions, including the $570 million purchase of CBI Home Health in April. The addition of Closing the Gap and nine Class C long-term care homes points to a larger and more diversified care platform, with a mix of in-home and facility-based services. On the balance sheet side, the $450 million senior unsecured notes and credit facility changes suggest the company is aligning its financing with this expanded scale. The 5.0% dividend increase, alongside a pre-tax gain realized from the sale of a vacated Class C property, reflects management’s current approach to capital returns while still funding growth. Investors may want to watch how integration of the new assets progresses, as well as how the updated capital structure affects interest costs and financial flexibility over time.공시 • May 09Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Buy Or Sell Opportunity • Apr 24Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to CA$29.61. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.Declared Dividend • Apr 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th April 2026 Payment date: 15th May 2026 Dividend yield will be 1.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Apr 17+ 1 more updateExtendicare Inc. Announces April 2026 Cash Dividend, Payable on May 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026.Buy Or Sell Opportunity • Apr 09Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 35% to CA$29.52. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.공시 • Apr 06Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026Recent Insider Transactions Derivative • Mar 20CEO, President & Director exercised options to buy CA$1.9m worth of stock.On the 17th of March, Michael Guerriere exercised options to buy 75k shares at a strike price of around CA$26.47, costing a total of CA$2.0m. This transaction amounted to 22% of their direct individual holding at the time of the trade. Since June 2025, Michael has owned 337.97k shares directly. Company insiders have collectively bought CA$6.9m more than they sold, via options and on-market transactions, in the last 12 months.Declared Dividend • Mar 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st March 2026 Payment date: 15th April 2026 Dividend yield will be 1.9%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Mar 19Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-ElectionExtendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate.Price Target Changed • Mar 01Price target increased by 15% to CA$29.08Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year.Reported Earnings • Feb 27Full year 2025 earnings released: EPS: CA$1.13 (vs CA$0.89 in FY 2024)Full year 2025 results: EPS: CA$1.13 (up from CA$0.89 in FY 2024). Revenue: CA$1.66b (up 13% from FY 2024). Net income: CA$96.7m (up 28% from FY 2024). Profit margin: 5.8% (up from 5.1% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.공시 • Feb 27Extendicare Inc. Increases Cash Dividend for the Month of March 2026Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases.Declared Dividend • Feb 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 27th February 2026 Payment date: 16th March 2026 Dividend yield will be 2.0%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Feb 17Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).분석 기사 • Feb 14Extendicare (TSE:EXE) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...공시 • Jan 27Extendicare Inc., Annual General Meeting, Apr 16, 2026Extendicare Inc., Annual General Meeting, Apr 16, 2026.분석 기사 • Jan 18Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 16th...Declared Dividend • Jan 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th January 2026 Payment date: 16th February 2026 Dividend yield will be 2.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jan 16Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026공시 • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).분석 기사 • Jan 14Do Extendicare's (TSE:EXE) Earnings Warrant Your Attention?It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...분석 기사 • Dec 27What Is Extendicare Inc.'s (TSE:EXE) Share Price Doing?While Extendicare Inc. ( TSE:EXE ) might not have the largest market cap around , it received a lot of attention from a...Declared Dividend • Dec 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st December 2025 Payment date: 15th January 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Dec 13Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Recent Insider Transactions • Dec 07Senior VP of ParaMed & CTO recently bought CA$213k worth of stockOn the 4th of December, Steve Paraskevopoulos bought around 10k shares on-market at roughly CA$22.40 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$259k more in shares than they have sold in the last 12 months.Price Target Changed • Nov 26Price target increased by 16% to CA$22.25Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year.공시 • Nov 20Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million.Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million. For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million. The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share. CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health.분석 기사 • Nov 19Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...Declared Dividend • Nov 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 28th November 2025 Payment date: 15th December 2025 Dividend yield will be 2.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 25% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CA$19.76, the stock trades at a trailing P/E ratio of 18.2x. Average forward P/E is 43x in the Healthcare industry in Canada. Total returns to shareholders of 253% over the past three years.Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: CA$0.28 (vs CA$0.19 in 3Q 2024)Third quarter 2025 results: EPS: CA$0.28 (up from CA$0.19 in 3Q 2024). Revenue: CA$440.3m (up 23% from 3Q 2024). Net income: CA$24.1m (up 48% from 3Q 2024). Profit margin: 5.5% (up from 4.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.Price Target Changed • Nov 14Price target increased by 14% to CA$18.75Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year.공시 • Nov 13Extendicare Inc. announces Monthly dividend, payable on December 15, 2025Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025.분석 기사 • Nov 13Even With A 26% Surge, Cautious Investors Are Not Rewarding Extendicare Inc.'s (TSE:EXE) Performance CompletelyDespite an already strong run, Extendicare Inc. ( TSE:EXE ) shares have been powering on, with a gain of 26% in the...공시 • Oct 15Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).공시 • Oct 07Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025Declared Dividend • Sep 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th September 2025 Payment date: 15th October 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Sep 15Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025.분석 기사 • Aug 17Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of September...Declared Dividend • Aug 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th August 2025 Payment date: 15th September 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.분석 기사 • Aug 10When Should You Buy Extendicare Inc. (TSE:EXE)?TSX:EXE 1 Year Share Price vs Fair Value Explore Extendicare's Fair Values from the Community and select yours...Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: CA$0.38 (vs CA$0.31 in 2Q 2024)Second quarter 2025 results: EPS: CA$0.38 (up from CA$0.31 in 2Q 2024). Revenue: CA$383.4m (up 10.0% from 2Q 2024). Net income: CA$31.9m (up 23% from 2Q 2024). Profit margin: 8.3% (up from 7.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.공시 • Aug 07Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.분석 기사 • Jul 19Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...Declared Dividend • Jul 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st July 2025 Payment date: 15th August 2025 Dividend yield will be 3.8%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jul 15Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).공시 • Jul 07Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025분석 기사 • Jun 20Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of July. This...Declared Dividend • Jun 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th June 2025 Payment date: 15th July 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).공시 • Jun 03Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc.Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction. Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025.분석 기사 • May 27Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 16th of June. This...Declared Dividend • May 16Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th May 2025 Payment date: 16th June 2025 Dividend yield will be 3.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions • May 11Independent Director recently bought CA$199k worth of stockOn the 8th of May, Donald Clow bought around 14k shares on-market at roughly CA$14.19 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$143k more in shares than they have sold in the last 12 months.Reported Earnings • May 07First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: CA$374.7m (up 2.1% from 1Q 2024). Net income: CA$15.0m (up 15% from 1Q 2024). Profit margin: 4.0% (up from 3.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada.공시 • May 07Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.분석 기사 • Apr 28Extendicare's (TSE:EXE) Dividend Will Be CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 15th of May. Based on...Declared Dividend • Apr 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th April 2025 Payment date: 15th May 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Apr 16Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).공시 • Apr 03Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025Declared Dividend • Mar 20Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st March 2025 Payment date: 15th April 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions Derivative • Mar 19CEO, President & Director exercised options to buy CA$1.0m worth of stock.On the 18th of March, Michael Guerriere exercised options to buy 79k shares at a strike price of around CA$13.03, costing a total of CA$1.0m. This transaction amounted to 31% of their direct individual holding at the time of the trade. Since March 2024, Michael has owned 258.82k shares directly. Company insiders have collectively bought CA$2.9m more than they sold, via options and on-market transactions, in the last 12 months.공시 • Mar 18Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).공시 • Mar 17Extendicare Inc., Annual General Meeting, May 27, 2025Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada분석 기사 • Mar 06Market Might Still Lack Some Conviction On Extendicare Inc. (TSE:EXE) Even After 28% Share Price BoostExtendicare Inc. ( TSE:EXE ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...Reported Earnings • Feb 28Full year 2024 earnings released: EPS: CA$0.89 (vs CA$0.40 in FY 2023)Full year 2024 results: EPS: CA$0.89 (up from CA$0.40 in FY 2023). Revenue: CA$1.47b (up 12% from FY 2023). Net income: CA$75.2m (up 121% from FY 2023). Profit margin: 5.1% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.공시 • Feb 28+ 1 more updateExtendicare Inc. Announces Dividend IncreaseExtendicare Inc. announced improved performance and growth in all three business segments has resulted in the dividend payout ratio dropping below 50%. Accordingly, the Company will increase its dividend by 5.0% to 4.2 cents per month effective with the dividend to be declared in March 2025.분석 기사 • Feb 21Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 17th of March. This means that the annual payment...Declared Dividend • Feb 20Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2025 Payment date: 17th March 2025 Dividend yield will be 4.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Feb 14Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Price Target Changed • Feb 05Price target increased by 8.6% to CA$11.40Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year.Declared Dividend • Jan 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st January 2025 Payment date: 14th February 2025 Dividend yield will be 4.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025.공시 • Jan 13Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025Declared Dividend • Dec 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st December 2024 Payment date: 15th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Dec 13Extendicare Announces December 2024 Dividend, Payable on January 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).분석 기사 • Nov 19Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High QualityWhen companies post strong earnings, the stock generally performs well, just like Extendicare Inc.'s ( TSE:EXE ) stock...Declared Dividend • Nov 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 29th November 2024 Payment date: 16th December 2024 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 14Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.공시 • Nov 13Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.Declared Dividend • Oct 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Oct 15Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).공시 • Oct 04Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024분석 기사 • Sep 20Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 15th of October. This means that the annual payment...Declared Dividend • Sep 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Sep 16Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).분석 기사 • Aug 16Extendicare's (TSE:EXE) Dividend Will Be CA$0.04Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.04 per share on 16th of September. This...Declared Dividend • Aug 15Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 5.8%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (69% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Price Target Changed • Aug 14Price target increased by 10% to CA$9.17Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year.Reported Earnings • Aug 13Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)Second quarter 2024 results: EPS: CA$0.30 (up from CA$0.023 in 2Q 2023). Revenue: CA$348.5m (up 13% from 2Q 2023). Net income: CA$25.9m (up CA$23.9m from 2Q 2023). Profit margin: 7.4% (up from 0.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.분석 기사 • Jul 23Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.04 per share on the 15th of August...Declared Dividend • Jul 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st July 2024 Payment date: 15th August 2024 Dividend yield will be 6.5%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.이익 및 매출 성장 예측TSX:EXE - 애널리스트 향후 추정치 및 과거 재무 데이터 (CAD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20282,553N/AN/AN/A212/31/20272,467N/A108N/A612/31/20262,250N/A-54N/A63/31/20261,75112288140N/A12/31/20251,66097104164N/A9/30/20251,59091100153N/A6/30/20251,5098379131N/A3/31/20251,4747775123N/A12/31/20241,46675102144N/A9/30/20241,4256496145N/A6/30/20241,3885927110N/A3/31/20241,34735-1293N/A12/31/20231,30534-10623N/A9/30/20231,26518-10037N/A6/30/20231,2521-9930N/A3/31/20231,2413-9717N/A12/31/20221,222-5-399N/A9/30/20221,217-1-1881N/A6/30/20221,193634116N/A3/31/20221,178446124N/A12/31/20211,1678-659N/A9/30/20211,114273191N/A6/30/20211,1265965110N/A3/31/20211,127495389N/A12/31/20201,1044288121N/A9/30/20201,141315680N/A6/30/20201,12722654N/A3/31/20201,129151951N/A12/31/20191,13215N/A45N/A9/30/20191,1301N/A41N/A6/30/20191,1274N/A27N/A3/31/20191,1236N/A42N/A12/31/20181,1208N/A39N/A9/30/20181,11327N/A49N/A6/30/20181,10626N/A52N/A3/31/20181,10030N/A46N/A12/31/20171,09732N/A47N/A9/30/20171,09335N/A54N/A6/30/20171,08838N/A33N/A3/31/20171,07538N/A33N/A12/31/20161,06131N/A0N/A9/30/20161,04625N/A1N/A6/30/20161,03227N/A-8N/A3/31/20161,00521N/A11N/A12/31/201594324N/A53N/A9/30/201589424N/A52N/A6/30/201584816N/A76N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: EXE 의 예상 수익 증가율이 절약률(3%)보다 높은지 판단하기에는 데이터가 부족합니다.수익 vs 시장: EXE 의 수익이 Canadian 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.고성장 수익: EXE 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.수익 대 시장: EXE 의 수익(연간 14.1%)이 Canadian 시장(연간 4.6%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: EXE 의 수익(연간 14.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: EXE의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/26 10:28종가2026/05/26 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Extendicare Inc.는 13명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kyle McPheeATB CormarkTom CallaghanBMO Capital Markets Equity ResearchTania Armstrong-WhitworthCanaccord Genuity10명의 분석가 더 보기
Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.
Price Target Changed • Mar 01Price target increased by 15% to CA$29.08Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year.
Price Target Changed • Nov 26Price target increased by 16% to CA$22.25Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year.
Price Target Changed • Nov 14Price target increased by 14% to CA$18.75Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year.
Price Target Changed • Feb 05Price target increased by 8.6% to CA$11.40Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year.
Price Target Changed • Aug 14Price target increased by 10% to CA$9.17Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year.
Recent Insider Transactions • May 17Independent Director recently bought CA$347k worth of stockOn the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months.
Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.
Reported Earnings • May 11First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025)First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year.
속보 • May 10Extendicare Expands Home Health Care With Major Acquisitions and Raises DividendExtendicare reported strong Q1 2026 results, with home health care cited as a key driver of performance. The company expanded its home health footprint through acquisitions of CBI Home Health, Closing the Gap and nine Class C long-term care homes. Extendicare issued $450 million of senior unsecured notes, restructured its credit facilities and announced a 5.0% increase in its monthly dividend. For you as an investor, the update highlights a clear push into home health services, supported by sizable acquisitions, including the $570 million purchase of CBI Home Health in April. The addition of Closing the Gap and nine Class C long-term care homes points to a larger and more diversified care platform, with a mix of in-home and facility-based services. On the balance sheet side, the $450 million senior unsecured notes and credit facility changes suggest the company is aligning its financing with this expanded scale. The 5.0% dividend increase, alongside a pre-tax gain realized from the sale of a vacated Class C property, reflects management’s current approach to capital returns while still funding growth. Investors may want to watch how integration of the new assets progresses, as well as how the updated capital structure affects interest costs and financial flexibility over time.
공시 • May 09Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Buy Or Sell Opportunity • Apr 24Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to CA$29.61. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.
Declared Dividend • Apr 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th April 2026 Payment date: 15th May 2026 Dividend yield will be 1.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Apr 17+ 1 more updateExtendicare Inc. Announces April 2026 Cash Dividend, Payable on May 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026.
Buy Or Sell Opportunity • Apr 09Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 35% to CA$29.52. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.
공시 • Apr 06Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026
Recent Insider Transactions Derivative • Mar 20CEO, President & Director exercised options to buy CA$1.9m worth of stock.On the 17th of March, Michael Guerriere exercised options to buy 75k shares at a strike price of around CA$26.47, costing a total of CA$2.0m. This transaction amounted to 22% of their direct individual holding at the time of the trade. Since June 2025, Michael has owned 337.97k shares directly. Company insiders have collectively bought CA$6.9m more than they sold, via options and on-market transactions, in the last 12 months.
Declared Dividend • Mar 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st March 2026 Payment date: 15th April 2026 Dividend yield will be 1.9%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Mar 19Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-ElectionExtendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate.
Price Target Changed • Mar 01Price target increased by 15% to CA$29.08Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year.
Reported Earnings • Feb 27Full year 2025 earnings released: EPS: CA$1.13 (vs CA$0.89 in FY 2024)Full year 2025 results: EPS: CA$1.13 (up from CA$0.89 in FY 2024). Revenue: CA$1.66b (up 13% from FY 2024). Net income: CA$96.7m (up 28% from FY 2024). Profit margin: 5.8% (up from 5.1% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.
공시 • Feb 27Extendicare Inc. Increases Cash Dividend for the Month of March 2026Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases.
Declared Dividend • Feb 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 27th February 2026 Payment date: 16th March 2026 Dividend yield will be 2.0%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Feb 17Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
분석 기사 • Feb 14Extendicare (TSE:EXE) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
공시 • Jan 27Extendicare Inc., Annual General Meeting, Apr 16, 2026Extendicare Inc., Annual General Meeting, Apr 16, 2026.
분석 기사 • Jan 18Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 16th...
Declared Dividend • Jan 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th January 2026 Payment date: 16th February 2026 Dividend yield will be 2.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jan 16Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026
공시 • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
분석 기사 • Jan 14Do Extendicare's (TSE:EXE) Earnings Warrant Your Attention?It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
분석 기사 • Dec 27What Is Extendicare Inc.'s (TSE:EXE) Share Price Doing?While Extendicare Inc. ( TSE:EXE ) might not have the largest market cap around , it received a lot of attention from a...
Declared Dividend • Dec 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st December 2025 Payment date: 15th January 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Dec 13Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Recent Insider Transactions • Dec 07Senior VP of ParaMed & CTO recently bought CA$213k worth of stockOn the 4th of December, Steve Paraskevopoulos bought around 10k shares on-market at roughly CA$22.40 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$259k more in shares than they have sold in the last 12 months.
Price Target Changed • Nov 26Price target increased by 16% to CA$22.25Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year.
공시 • Nov 20Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million.Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million. For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million. The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share. CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health.
분석 기사 • Nov 19Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...
Declared Dividend • Nov 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 28th November 2025 Payment date: 15th December 2025 Dividend yield will be 2.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 25% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CA$19.76, the stock trades at a trailing P/E ratio of 18.2x. Average forward P/E is 43x in the Healthcare industry in Canada. Total returns to shareholders of 253% over the past three years.
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: CA$0.28 (vs CA$0.19 in 3Q 2024)Third quarter 2025 results: EPS: CA$0.28 (up from CA$0.19 in 3Q 2024). Revenue: CA$440.3m (up 23% from 3Q 2024). Net income: CA$24.1m (up 48% from 3Q 2024). Profit margin: 5.5% (up from 4.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Nov 14Price target increased by 14% to CA$18.75Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year.
공시 • Nov 13Extendicare Inc. announces Monthly dividend, payable on December 15, 2025Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025.
분석 기사 • Nov 13Even With A 26% Surge, Cautious Investors Are Not Rewarding Extendicare Inc.'s (TSE:EXE) Performance CompletelyDespite an already strong run, Extendicare Inc. ( TSE:EXE ) shares have been powering on, with a gain of 26% in the...
공시 • Oct 15Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
공시 • Oct 07Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025
Declared Dividend • Sep 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th September 2025 Payment date: 15th October 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Sep 15Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025.
분석 기사 • Aug 17Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of September...
Declared Dividend • Aug 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th August 2025 Payment date: 15th September 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
분석 기사 • Aug 10When Should You Buy Extendicare Inc. (TSE:EXE)?TSX:EXE 1 Year Share Price vs Fair Value Explore Extendicare's Fair Values from the Community and select yours...
Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: CA$0.38 (vs CA$0.31 in 2Q 2024)Second quarter 2025 results: EPS: CA$0.38 (up from CA$0.31 in 2Q 2024). Revenue: CA$383.4m (up 10.0% from 2Q 2024). Net income: CA$31.9m (up 23% from 2Q 2024). Profit margin: 8.3% (up from 7.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
공시 • Aug 07Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.
분석 기사 • Jul 19Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...
Declared Dividend • Jul 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st July 2025 Payment date: 15th August 2025 Dividend yield will be 3.8%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jul 15Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
공시 • Jul 07Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
분석 기사 • Jun 20Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of July. This...
Declared Dividend • Jun 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th June 2025 Payment date: 15th July 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
공시 • Jun 03Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc.Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction. Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025.
분석 기사 • May 27Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 16th of June. This...
Declared Dividend • May 16Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th May 2025 Payment date: 16th June 2025 Dividend yield will be 3.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions • May 11Independent Director recently bought CA$199k worth of stockOn the 8th of May, Donald Clow bought around 14k shares on-market at roughly CA$14.19 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$143k more in shares than they have sold in the last 12 months.
Reported Earnings • May 07First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: CA$374.7m (up 2.1% from 1Q 2024). Net income: CA$15.0m (up 15% from 1Q 2024). Profit margin: 4.0% (up from 3.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada.
공시 • May 07Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.
분석 기사 • Apr 28Extendicare's (TSE:EXE) Dividend Will Be CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 15th of May. Based on...
Declared Dividend • Apr 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th April 2025 Payment date: 15th May 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Apr 16Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
공시 • Apr 03Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025
Declared Dividend • Mar 20Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st March 2025 Payment date: 15th April 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions Derivative • Mar 19CEO, President & Director exercised options to buy CA$1.0m worth of stock.On the 18th of March, Michael Guerriere exercised options to buy 79k shares at a strike price of around CA$13.03, costing a total of CA$1.0m. This transaction amounted to 31% of their direct individual holding at the time of the trade. Since March 2024, Michael has owned 258.82k shares directly. Company insiders have collectively bought CA$2.9m more than they sold, via options and on-market transactions, in the last 12 months.
공시 • Mar 18Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
공시 • Mar 17Extendicare Inc., Annual General Meeting, May 27, 2025Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada
분석 기사 • Mar 06Market Might Still Lack Some Conviction On Extendicare Inc. (TSE:EXE) Even After 28% Share Price BoostExtendicare Inc. ( TSE:EXE ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...
Reported Earnings • Feb 28Full year 2024 earnings released: EPS: CA$0.89 (vs CA$0.40 in FY 2023)Full year 2024 results: EPS: CA$0.89 (up from CA$0.40 in FY 2023). Revenue: CA$1.47b (up 12% from FY 2023). Net income: CA$75.2m (up 121% from FY 2023). Profit margin: 5.1% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
공시 • Feb 28+ 1 more updateExtendicare Inc. Announces Dividend IncreaseExtendicare Inc. announced improved performance and growth in all three business segments has resulted in the dividend payout ratio dropping below 50%. Accordingly, the Company will increase its dividend by 5.0% to 4.2 cents per month effective with the dividend to be declared in March 2025.
분석 기사 • Feb 21Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 17th of March. This means that the annual payment...
Declared Dividend • Feb 20Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2025 Payment date: 17th March 2025 Dividend yield will be 4.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Feb 14Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Price Target Changed • Feb 05Price target increased by 8.6% to CA$11.40Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year.
Declared Dividend • Jan 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st January 2025 Payment date: 14th February 2025 Dividend yield will be 4.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025.
공시 • Jan 13Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025
Declared Dividend • Dec 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st December 2024 Payment date: 15th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Dec 13Extendicare Announces December 2024 Dividend, Payable on January 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
분석 기사 • Nov 19Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High QualityWhen companies post strong earnings, the stock generally performs well, just like Extendicare Inc.'s ( TSE:EXE ) stock...
Declared Dividend • Nov 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 29th November 2024 Payment date: 16th December 2024 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 14Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
공시 • Nov 13Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.
Declared Dividend • Oct 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Oct 15Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
공시 • Oct 04Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024
분석 기사 • Sep 20Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 15th of October. This means that the annual payment...
Declared Dividend • Sep 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Sep 16Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
분석 기사 • Aug 16Extendicare's (TSE:EXE) Dividend Will Be CA$0.04Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.04 per share on 16th of September. This...
Declared Dividend • Aug 15Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 5.8%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (69% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Price Target Changed • Aug 14Price target increased by 10% to CA$9.17Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year.
Reported Earnings • Aug 13Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)Second quarter 2024 results: EPS: CA$0.30 (up from CA$0.023 in 2Q 2023). Revenue: CA$348.5m (up 13% from 2Q 2023). Net income: CA$25.9m (up CA$23.9m from 2Q 2023). Profit margin: 7.4% (up from 0.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
분석 기사 • Jul 23Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.04 per share on the 15th of August...
Declared Dividend • Jul 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st July 2024 Payment date: 15th August 2024 Dividend yield will be 6.5%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.